IL318634A - תכשירים מונעי דימום ושיטות המרבות אותם - Google Patents

תכשירים מונעי דימום ושיטות המרבות אותם

Info

Publication number
IL318634A
IL318634A IL318634A IL31863425A IL318634A IL 318634 A IL318634 A IL 318634A IL 318634 A IL318634 A IL 318634A IL 31863425 A IL31863425 A IL 31863425A IL 318634 A IL318634 A IL 318634A
Authority
IL
Israel
Prior art keywords
haemorrhage
same
methods involving
inhibiting compositions
inhibiting
Prior art date
Application number
IL318634A
Other languages
English (en)
Inventor
Birgit Ter-Borch Gram Lilienfeldt Schjoldager
Original Assignee
Stellaris Pharmaceuticals Aps
Schjoldager Birgit Ter Borch Gram Lilienfeldt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US18/210,190 external-priority patent/US20240066106A1/en
Application filed by Stellaris Pharmaceuticals Aps, Schjoldager Birgit Ter Borch Gram Lilienfeldt filed Critical Stellaris Pharmaceuticals Aps
Publication of IL318634A publication Critical patent/IL318634A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L3/00—Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
    • C08L3/02—Starch; Degradation products thereof, e.g. dextrin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21021—Coagulation factor VIIa (3.4.21.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL318634A 2022-08-26 2023-08-24 תכשירים מונעי דימום ושיטות המרבות אותם IL318634A (he)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22192409 2022-08-26
US18/210,190 US20240066106A1 (en) 2022-08-26 2023-06-15 Haemorrhage inhibiting compositions and methods involving the same
PCT/EP2023/073194 WO2024042148A1 (en) 2022-08-26 2023-08-24 Haemorrhage inhibiting compositions and methods involving the same

Publications (1)

Publication Number Publication Date
IL318634A true IL318634A (he) 2025-03-01

Family

ID=87800786

Family Applications (1)

Application Number Title Priority Date Filing Date
IL318634A IL318634A (he) 2022-08-26 2023-08-24 תכשירים מונעי דימום ושיטות המרבות אותם

Country Status (5)

Country Link
EP (1) EP4577186A1 (he)
AU (1) AU2023329098A1 (he)
CA (1) CA3263268A1 (he)
IL (1) IL318634A (he)
WO (1) WO2024042148A1 (he)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR860984B (en) 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
DK223389D0 (da) 1989-05-05 1989-05-05 Ferrosan As Saarsvamp
JPH07500095A (ja) 1991-10-11 1995-01-05 ノボ　ノルディスク　アクティーゼルスカブ 局所止血用止血組成物
US20040106344A1 (en) 2002-06-28 2004-06-03 Looney Dwayne Lee Hemostatic wound dressings containing proteinaceous polymers
ES2399138T3 (es) 2006-03-16 2013-03-26 Stellaris Pharmaceuticals Aps Tratamiento local con factor VII
CN101541012A (zh) 2008-03-21 2009-09-23 夏普株式会社 干扰过载指示生成方法、干扰过载指示触发方法、干扰过载指示方法和基站

Also Published As

Publication number Publication date
EP4577186A1 (en) 2025-07-02
AU2023329098A1 (en) 2025-02-06
CA3263268A1 (en) 2024-02-29
WO2024042148A1 (en) 2024-02-29

Similar Documents

Publication Publication Date Title
PL4208045T3 (pl) Kompozycje i sposoby
GB202111040D0 (en) Compositions and methods
GB202108585D0 (en) Methods and compositions
GB202004677D0 (en) Methods and compositions
IL318634A (he) תכשירים מונעי דימום ושיטות המרבות אותם
GB202316199D0 (en) Compositions and methods and uses thereto
IL304824A (he) שיטות ותכשירי פוספרופופול
GB202209335D0 (en) Compositions and uses thereof
GB202116554D0 (en) Methods and compositions
GB202110091D0 (en) Methods and compositions
GB2635318B (en) Methods and compositions
GB202409672D0 (en) compositions and methods and uses related thereto
GB202406838D0 (en) Compositions and methods and uses related thereto
IL321428A (he) תרכובות ושיטות
GB202316109D0 (en) Methods and compositions
GB202311858D0 (en) Methods and compositions
GB202308901D0 (en) Methods and compositions
GB202307563D0 (en) Methods and compositions
GB202305427D0 (en) Methods and compositions
GB202408093D0 (en) Compositions and methods
GB202304240D0 (en) Compositions and methods
IL315882A (he) נוגדנים כנגד ilt4, תכשירים ושיטות
GB202214719D0 (en) Compositions and methods
GB202219851D0 (en) Compositions and methods
GB202306393D0 (en) Trna-based methods and related compositions